Screening of FOXD3 targets in lung cancer via bioinformatics analysis

Jiang,Wenhua; Liu,Pengfei; Li,Xiaodong

doi:10.3892/ol.2017.7685

Screening of FOXD3 targets in lung cancer via bioinformatics analysis

Authors:
- Wenhua Jiang
- Pengfei Liu
- Xiaodong Li
View Affiliations

Affiliations: Department of Radiotherapy, The Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China, Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China
Published online on: December 21, 2017 https://doi.org/10.3892/ol.2017.7685
Pages: 3214-3220

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of the present study was to explore the targets of forkhead box D3 (FOXD3) in lung cancer, and thus contribute to the diagnosis and therapy of the disease. The gene expression profile of GSE64513 was downloaded from the Gene Expression Omnibus database. The dataset contained 3 FOXD3 knockout A549 lung cancer cell samples and 3 normal A549 cell samples. The differentially expressed genes (DEGs) between the FOXD3‑knockout and normal A549 cells were identified using the limma package in R. The alternative splicing genes (ASGs) in FOXD3‑knockout samples were identified by Replicate Multivariate Analysis of Transcript Splicing software. The Database for Annotation, Visualization and Integrated Discovery was used to identify the enriched functions and pathways of DEGs and ASGs. A protein‑protein interaction (PPI) network was constructed based on results from the Search Tool for the Retrieval of Interacting Genes database and visualized using Cytoscape software. A total of 1,853 DEGs and 2,249 ASGs were identified in FOXD3‑knockout A549 cells compared with normal A549 cells. The DEGs were enriched in 338 Gene Ontology (GO) terms and 21 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and the ASGs were enriched in 470 GO terms and 22 KEGG pathways. A total of 199 overlaps between the DEGs and the ASGs were identified; a PPI network constructed based on the overlapping genes contained 97 nodes and 115 pairs. FOXD3 may serve an important role in regulating the growth, migration and proliferation of tumor cells in lung cancer. The present study indicates that a number of genes, including AURKA and NOS3, may be targets of FOXD3, mediating its effect in lung cancer.

View Figures

View References

1	Reck M, Heigener DF, Mok T, Soria JC and Rabe KF: Management of non-small-cell lung cancer: Recent developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
2	Grunnet M and Sorensen JB: Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 76:138–143. 2012. View Article : Google Scholar : PubMed/NCBI
3	Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of disease study 2010. Lancet. 380:2095–2128. 2012. View Article : Google Scholar : PubMed/NCBI
4	Wang Y, Chen J, Wu S, Hu C, Li X, Wang Y, Yang Y, Rajan N, Chen Y, Chen Y, et al: Clinical effectiveness and clinical toxicity associated with platinum-based doublets in the first-line setting for advanced non-squamous non-small cell lung cancer in Chinese patients: A retrospective cohort study. BMC Cancer. 14:9402014. View Article : Google Scholar : PubMed/NCBI
5	Cooper WA, Lam DC, O'Toole SA and Minna JD: Molecular biology of lung cancer. Lung Cancer. 42:378–386. 2004.
6	Weigel D and Jäckle H: The fork head domain: A novel DNA binding motif of eukaryotic transcription factors? Cell. 63:455–456. 1990. View Article : Google Scholar : PubMed/NCBI
7	Sutton J, Costa R, Klug M, Field L, Xu D, Largaespada DA, Fletcher CF, Jenkins NA, Copeland NG, Klemsz M and Hromas R: Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells. J Biol Chem. 271:23126–23133. 1996. View Article : Google Scholar : PubMed/NCBI
8	Yan JH, Zhao CL, Ding LB and Zhou X: FOXD3 suppresses tumor growth and angiogenesis in non-small cell lung cancer. Biochem Biophys Res Commun. 466:111–116. 2015. View Article : Google Scholar : PubMed/NCBI
9	Cheng AS, Li MS, Kang W, Cheng VY, Chou JL, Lau SS, Go MY, Lee CC, Ling TK, Ng EK, et al: Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology. 144:122–133.e9. 2013. View Article : Google Scholar : PubMed/NCBI
10	Abel EV and Aplin AE: FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells. Cancer Res. 70:2891–2900. 2010. View Article : Google Scholar : PubMed/NCBI
11	Katiyar P and Aplin AE: FOXD3 regulates migration properties and Rnd3 expression in melanoma cells. Mol Cancer Res. 9:545–552. 2011. View Article : Google Scholar : PubMed/NCBI
12	Li D, Mei H, Qi M, Yang D, Zhao X, Xiang X, Pu J, Huang K, Zheng L and Tong Q: FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma. Oncotarget. 4:2021–2044. 2013. View Article : Google Scholar : PubMed/NCBI
13	Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R and Salzberg SL: TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14:R362013. View Article : Google Scholar : PubMed/NCBI
14	Anders S, Pyl PT and Huber W: HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics. 31:166–169. 2015. View Article : Google Scholar : PubMed/NCBI
15	Culpepper SA and Aguinis HR: Is for Revolution: A Cutting-Edge, free, open source statistical package. Organizational Res Methods. 13:735–740. 2011. View Article : Google Scholar
16	Warnes GR, Bolker B, Bonebakker L, et al: Gplots: Various R programming tools for plotting data. R package version 2.12. 1. http://CRAN.R-project.org/package=gplots
17	Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, Zhou Q and Xing Y: rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci USA. 111:pp. E5593–E5601. 2014; View Article : Google Scholar : PubMed/NCBI
18	Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC and Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4:P32003. View Article : Google Scholar : PubMed/NCBI
19	Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, et al: The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39(Database issue): D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
20	Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C and Jensen LJ: STRING v9.1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41(Database issue): D808–D815. 2013.PubMed/NCBI
21	Smoot ME, Ono K, Ruscheinski J, Wang PL and Ideker T: Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
22	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
23	Yang P: Epidemiology of lung cancer prognosis: Quantity and quality of life. Methods Mol Biol. 471:469–86. 2009. View Article : Google Scholar : PubMed/NCBI
24	Schäfer M and Werner S: Cancer as an overhealing wound: An old hypothesis revisited. Nat Rev Mol Cell Biol. 9:628–638. 2008. View Article : Google Scholar : PubMed/NCBI
25	Troester MA, Lee MM, Carter M, Fan C, Cowan DW, Perez ER, Pirone JR, Perou CM, Jerry DJ and Schneider SS: Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res. 15:7020–7028. 2009. View Article : Google Scholar : PubMed/NCBI
26	Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sørlie T, Dai H, He YD, van't Veer LJ, Bartelink H, et al: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA. 102:pp. 3738–3743. 2005; View Article : Google Scholar : PubMed/NCBI
27	Singleton P: Bacteria in Biology, Biotechnology, and Medicine. 5th. John Wiley; Hoboken, NJ: pp. 444–454. 1999
28	Sok M, Sentjurc M, Schara M, Stare J and Rott T: Cell membrane fluidity and prognosis of lung cancer. Ann Thorac Surg. 73:1567–1571. 2002. View Article : Google Scholar : PubMed/NCBI
29	Nakazawa I and Iwaizumi M: A role of the cancer cell membrane fluidity in the cancer metastases: An ESR study. Tohoku J Exp Med. 157:193–198. 1989. View Article : Google Scholar : PubMed/NCBI
30	Deliconstantinos G: Physiological aspects of membrane lipid fluidity in malignancy. Anticancer Res. 7:1011–1021. 1987.PubMed/NCBI
31	Nakazawa I and Iwaizumi M: A role of the cancer cell membrane fluidity in the cancer metastases: Aan ESR study. Tohoku J Exp Med. 157:193–198. 1989. View Article : Google Scholar : PubMed/NCBI
32	Winey M, Mamay CL, O'Toole ET, Mastronarde DN, Giddings TH Jr, McDonald KL and McIntosh JR: Three-dimensional ultrastructural analysis of the Saccharomyces cerevisiae mitotic spindle. J Cell Biol. 129:1601–1615. 1995. View Article : Google Scholar : PubMed/NCBI
33	Jana SS, Kawamoto S and Adelstein RS: A specific isoform of nonmuscle myosin II-C is required for cytokinesis in a tumor cell line. J Biol Chem. 281:24662–24670. 2006. View Article : Google Scholar : PubMed/NCBI
34	Weisiger RA: Cytosolic fatty acid binding proteins catalyze two distinct steps in intracellular transport of their ligands. Mol Cell Biochem. 239:35–43. 2002. View Article : Google Scholar : PubMed/NCBI
35	Li XB, Gu JD and Zhou QH: Review of aerobic glycolysis and its key enzymes-new targets for lung cancer therapy. Thoracic Cancer. 6:17–24. 2015. View Article : Google Scholar : PubMed/NCBI
36	Jingye Z, Zining L, Peng L, Jun Q, Xinwei L, Lu W, Wei F, Liang C, Xunbin W and Cong L: Selective imaging and cancer cell death via pH switchable near-infrared fluorescence and photothermal effects. Chem Sci. 7:5995–6005. 2016. View Article : Google Scholar
37	Ackermann S, Kocak H, Hero B, Ehemann V, Kahlert Y, Oberthuer A, Roels F, Theißen J, Odenthal M, Berthold F and Fischer M: FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma. Bmc Cancer. 14:8402014. View Article : Google Scholar : PubMed/NCBI
38	Kos R, Reedy MV, Johnson RL and Erickson CA: The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos. Development. 128:1467–1479. 2001.PubMed/NCBI
39	Wang C, Huang Y and Dai W: Tumor suppression function of FoxD3 in lung cancer. Ir J Med Sci. 185:547–553. 2016. View Article : Google Scholar : PubMed/NCBI
40	Pópulo H, Lopes JM and Soares P: The mTOR signalling pathway in human cancer. Int J Mol Sci. 13:1886–1918. 2012. View Article : Google Scholar : PubMed/NCBI
41	Castaño-Rodríguez N, Kaakoush NO, Goh KL, Fock KM and Mitchell HM: The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: A case-control study and gene expression analyses. PLoS One. 9:e988992014. View Article : Google Scholar : PubMed/NCBI
42	Lens SM, Voest EE and Medema RH: Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer. 10:825–841. 2010. View Article : Google Scholar : PubMed/NCBI
43	Ma ZL, Zhang BJ, Wang DT, Li X, Wei JL, Zhao BT, Jin Y, Li YL and Jin YX: Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer. Oncotarget. 6:20111–20120. 2015.PubMed/NCBI
44	Xu W, Charles IG, Moncada S, Gorman P, Sheer D, Liu L and Emson P: Mapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectively. Genomics. 21:419–422. 1994. View Article : Google Scholar : PubMed/NCBI
45	Arıkan S, Cacina C, Guler E, Çulcu S, Tuna G and Yaylımeraltan I: The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population. Mol Biol Rep. 39:3245–3249. 2012. View Article : Google Scholar : PubMed/NCBI
46	Lee KM, Choi JY, Lee JE, Noh DY, Ahn SH, Han W, Yoo KY, Hayes RB and Kang D: Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement. Breast Cancer Res Treat. 106:433–438. 2007. View Article : Google Scholar : PubMed/NCBI
47	Wang JH, Chen LB, Heng-Hui MA and Meng K: Expressions of NOS2 and NOS3 in human non-small cell lung cancer and the relationship with tumor angiogenesis and lymph node metastasis. J Med Postgraduates. 2004.
48	Stahl JM, Sharma A, Cheung M, Zimmerman M, Cheng JQ, Bosenberg MW, Kester M, Sandirasegarane L and Robertson GP: Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res. 64:7002–7010. 2004. View Article : Google Scholar : PubMed/NCBI
49	Terasaka Y, Miyazaki D, Yakura K, Haruki T and Inoue Y: Induction of IL-6 in transcriptional networks in corneal epithelial cells after herpes simplex virus type 1 infection. Invest Ophthalmol Vis Sci. 51:2441–2449. 2010. View Article : Google Scholar : PubMed/NCBI
50	Balamuth NJ, Wood A, Wang Q, Jagannathan J, Mayes P, Zhang Z, Chen Z, Rappaport E, Courtright J, Pawel B, et al: Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer Res. 70:2749–2758. 2010. View Article : Google Scholar : PubMed/NCBI
51	Weiss MB, Abel EV, Dadpey N and Aplin AE: FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma. Mol Cancer Res. 12:1314–1323. 2014. View Article : Google Scholar : PubMed/NCBI